Cargando…

Mutational screening of inverted formin 2 in adult-onset focal segmental glomerulosclerosis or minimal change patients from the Czech Republic

BACKGROUND: Mutations in INF2 are frequently responsible for focal segmental glomerulosclerosis (FSGS), which is a common cause of end stage renal disease (ESRD); additionally, they are also connected with Charcot-Marie-Tooth neuropathy. INF2 encodes for inverted formin 2. This protein participates...

Descripción completa

Detalles Bibliográficos
Autores principales: Safarikova, Marketa, Stekrova, Jitka, Honsova, Eva, Horinova, Vera, Tesar, Vladimir, Reiterova, Jana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6102913/
https://www.ncbi.nlm.nih.gov/pubmed/30126379
http://dx.doi.org/10.1186/s12881-018-0667-9
_version_ 1783349267262341120
author Safarikova, Marketa
Stekrova, Jitka
Honsova, Eva
Horinova, Vera
Tesar, Vladimir
Reiterova, Jana
author_facet Safarikova, Marketa
Stekrova, Jitka
Honsova, Eva
Horinova, Vera
Tesar, Vladimir
Reiterova, Jana
author_sort Safarikova, Marketa
collection PubMed
description BACKGROUND: Mutations in INF2 are frequently responsible for focal segmental glomerulosclerosis (FSGS), which is a common cause of end stage renal disease (ESRD); additionally, they are also connected with Charcot-Marie-Tooth neuropathy. INF2 encodes for inverted formin 2. This protein participates in regulation of the dynamics of the actin cytoskeleton, involving not only the polymerisation, but also the depolymerisation of filaments. The present study is the first mutational analysis of INF2 done in the Czech Republic. METHODS: Mutational analysis of INF2 was performed on 109 patients (mean age at onset 41.44 ± 18.91 years) with FSGS or minimal change disease (MCD); and also in 6 patients without renal biopsy who had already developed chronic kidney disease (CKD)/ESRD at the time of diagnosis. We used high resolution melting method (HRM), with subsequent Sanger sequencing, in suspect samples from HRM analysis. The HRM method is an effective method for the screening of large cohorts of patients. RESULTS: Two pathogenic mutations (p.Arg214His and p.Arg218Gln) were detected in INF2. The first (p.Arg214His) was identified in the FSGS patient with a positive family history. The second mutation (p.Arg218Gln) was found in two brothers with ESRD of unknown etiology. The most frequent sequence change was the substitution p.P35P, the incidence of which corresponded with the frequencies available in the ExAC Browser and gnomAD Browser databases. This analysis also detected different exonic and intronic changes that probably did not influence the phenotype of the included patients. CONCLUSIONS: The INF2 mutational screening is useful in familial FSGS cases as well as in patients with an unknown cause for their ESRD, but with a positive family history. INF2 seems to be not only the cause of FSGS, but also of ESRD of unknown etiology. Our study has confirmed that the HRM analysis is a very useful method for the identification of single nucleotide substitutions.
format Online
Article
Text
id pubmed-6102913
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-61029132018-08-30 Mutational screening of inverted formin 2 in adult-onset focal segmental glomerulosclerosis or minimal change patients from the Czech Republic Safarikova, Marketa Stekrova, Jitka Honsova, Eva Horinova, Vera Tesar, Vladimir Reiterova, Jana BMC Med Genet Research Article BACKGROUND: Mutations in INF2 are frequently responsible for focal segmental glomerulosclerosis (FSGS), which is a common cause of end stage renal disease (ESRD); additionally, they are also connected with Charcot-Marie-Tooth neuropathy. INF2 encodes for inverted formin 2. This protein participates in regulation of the dynamics of the actin cytoskeleton, involving not only the polymerisation, but also the depolymerisation of filaments. The present study is the first mutational analysis of INF2 done in the Czech Republic. METHODS: Mutational analysis of INF2 was performed on 109 patients (mean age at onset 41.44 ± 18.91 years) with FSGS or minimal change disease (MCD); and also in 6 patients without renal biopsy who had already developed chronic kidney disease (CKD)/ESRD at the time of diagnosis. We used high resolution melting method (HRM), with subsequent Sanger sequencing, in suspect samples from HRM analysis. The HRM method is an effective method for the screening of large cohorts of patients. RESULTS: Two pathogenic mutations (p.Arg214His and p.Arg218Gln) were detected in INF2. The first (p.Arg214His) was identified in the FSGS patient with a positive family history. The second mutation (p.Arg218Gln) was found in two brothers with ESRD of unknown etiology. The most frequent sequence change was the substitution p.P35P, the incidence of which corresponded with the frequencies available in the ExAC Browser and gnomAD Browser databases. This analysis also detected different exonic and intronic changes that probably did not influence the phenotype of the included patients. CONCLUSIONS: The INF2 mutational screening is useful in familial FSGS cases as well as in patients with an unknown cause for their ESRD, but with a positive family history. INF2 seems to be not only the cause of FSGS, but also of ESRD of unknown etiology. Our study has confirmed that the HRM analysis is a very useful method for the identification of single nucleotide substitutions. BioMed Central 2018-08-20 /pmc/articles/PMC6102913/ /pubmed/30126379 http://dx.doi.org/10.1186/s12881-018-0667-9 Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Safarikova, Marketa
Stekrova, Jitka
Honsova, Eva
Horinova, Vera
Tesar, Vladimir
Reiterova, Jana
Mutational screening of inverted formin 2 in adult-onset focal segmental glomerulosclerosis or minimal change patients from the Czech Republic
title Mutational screening of inverted formin 2 in adult-onset focal segmental glomerulosclerosis or minimal change patients from the Czech Republic
title_full Mutational screening of inverted formin 2 in adult-onset focal segmental glomerulosclerosis or minimal change patients from the Czech Republic
title_fullStr Mutational screening of inverted formin 2 in adult-onset focal segmental glomerulosclerosis or minimal change patients from the Czech Republic
title_full_unstemmed Mutational screening of inverted formin 2 in adult-onset focal segmental glomerulosclerosis or minimal change patients from the Czech Republic
title_short Mutational screening of inverted formin 2 in adult-onset focal segmental glomerulosclerosis or minimal change patients from the Czech Republic
title_sort mutational screening of inverted formin 2 in adult-onset focal segmental glomerulosclerosis or minimal change patients from the czech republic
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6102913/
https://www.ncbi.nlm.nih.gov/pubmed/30126379
http://dx.doi.org/10.1186/s12881-018-0667-9
work_keys_str_mv AT safarikovamarketa mutationalscreeningofinvertedformin2inadultonsetfocalsegmentalglomerulosclerosisorminimalchangepatientsfromtheczechrepublic
AT stekrovajitka mutationalscreeningofinvertedformin2inadultonsetfocalsegmentalglomerulosclerosisorminimalchangepatientsfromtheczechrepublic
AT honsovaeva mutationalscreeningofinvertedformin2inadultonsetfocalsegmentalglomerulosclerosisorminimalchangepatientsfromtheczechrepublic
AT horinovavera mutationalscreeningofinvertedformin2inadultonsetfocalsegmentalglomerulosclerosisorminimalchangepatientsfromtheczechrepublic
AT tesarvladimir mutationalscreeningofinvertedformin2inadultonsetfocalsegmentalglomerulosclerosisorminimalchangepatientsfromtheczechrepublic
AT reiterovajana mutationalscreeningofinvertedformin2inadultonsetfocalsegmentalglomerulosclerosisorminimalchangepatientsfromtheczechrepublic